Fear of negative and positive evaluation and reactivity to social-evaluative videos in social anxiety disorder.

Social anxiety disorder (SAD) is marked by persistent fear of being scrutinized by others. This and most diagnostic symptoms relate to some form of fear of negative evaluation (FNE). More recent accounts of SAD, such as the Bivalent Fear of Evaluation Model, however, complement FNE with fear of positive evaluation (FPE), described as distress and avoidance of positive feedback. An explicit test of the incremental validity of FPE in discriminating SAD patients from controls - over and on top of the explanatory power of FPE - is currently missing and generally, well controlled laboratory experiments with positive and negative social stimuli in this patient group are rare. To fill this gap, we exposed 35 patients with SAD and healthy controls (HCs) to short social-evaluative video clips with actors expressing negative and positive as well as neutral statements while recording reactivity on experiential measures (valence, arousal, and approval ratings) as well as on facial electromyography and electrocardiography. In addition, participants completed questionnaire measures of FNE and FPE. Results revealed that FPE questionnaire scores as well as experiential (valence and appreciation) and electromyographical reactivity measures to positive videos improved prediction of group membership beyond the predictive power of FNE questionnaires scores and reactivity to negative videos. Results document the importance of FPE to more fully characterize and understand social anxiety and SAD. Implications include amendments to future diagnostic criteria, theoretical models, and treatment approaches for SAD.

[Pilot Study of the Feasibility of a Short Biofeedback Treatment of Chronic Headache in the Outpatient Care System]. / Pilotstudie zur Durchführbarkeit einer Biofeedbackkompaktbehandlung bei chronifizierten Kopfschmerzen in der ambulanten Versorgung.

Introduction: Although biofeedback has been shown to be an effective treatment of tension-type headache and migraine, it has not been well implemented in the outpatient care system yet. Central aims of this randomized controlled pilot study were to examine the feasibility and implementation of a short biofeedback treatment of chronic headache in the outpatient care system, to estimate standardized effect sizes for treatment outcome, and to investigate the influence of expectancies on treatment outcomes. Methods: In this pilot study, the patients (N=18) were diagnosed according to the criteria defined by the International Headache Society and randomized afterwards. Patients received 8-11 sessions of biofeedback (depending on the indication: Electromyography biofeedback, Vasoconstriction-/Vasodilatation training or a combination of both). Outcome assessments took place before and after the biofeedback treatment via questionnaires. Hedges' g was computed based on change scores of treatment expectancies, session performance (patients and therapists), headache-specific self-efficacy (Headache Management Self-efficacy Scale-Short form), headache-related variables (Pain Disability Index, German Pain Coping Questionnaire) and comorbid strain (Hospital Anxiety and Depression Scale). Pearson-correlations were calculated for the relations of change scores. Results: Effect sizes for most of the assessed expectancies and coping were high (g=0.94-1.45). Improvements in the willingness to practice and disability in everyday life were moderate (g=0.40-0.51). The correlations between patients' expectancies and disability or coping were medium (r=- 0,42 - 0.41). Results showed a moderate negative correlation between the patient-rated session performance and depression (r=-0.33). Discussion and Conclusion: The short biofeedback treatment showed a good feasibility and implementation in the outpatient care system, with pilot results indicating effectiveness. The documented associations between patient-rated and therapist-rated expectancies and the treatment outcome emphasize the importance of the assessment of expectancies.

Cognitive-behavioural therapy for patients with multiple somatoform symptoms--a randomised controlled trial in tertiary care.

OBJECTIVE: (a) To evaluate the effect of a cognitive-behavioural inpatient treatment and (b) to analyse the differential efficacy of an additional ("soma") group management training of somatisation. METHODS: The final sample consisted of 191 patients with somatisation syndrome (patients with at least eight DSM-IV somatoform symptoms). Patients were randomly assigned to (I) "standard treatment + soma" or (II) "standard treatment + relaxation training." A waiting control group consisted of 34 patients. All patients were diagnosed with a structured clinical interview for DSM-IV and received an interview on medical consulting behaviour and questionnaires concerning somatoform symptoms, general psychopathology, subjective health status, and life satisfaction. RESULTS: Results show high impairment of the sample prior to treatment. At the 1-year follow-up, all outcome criteria were significantly reduced. The differential effect of the additional soma treatment was significant only for a reduction of visits to the doctor. Greatest longitudinal effect sizes were found for the reduction of somatoform symptoms. CONCLUSION: Considering the subjects' high initial impairment, the outcome results are encouraging. The specific effect on health care use highlights the socioeconomic relevance.